Increasing age at diagnosis of chronic uveitis (p=0.01), presence of posterior synechiae (p=0.01) and positive chest HRCT (p=0.01) were factors associated with probability to have a PET scan with signs for sarcoidosisConclusion increasing age at the diagnosis of uveitis, presence of posterior ...
The objective was to investigate longitudinal changes in fluorodeoxyglucose PET scan (FDG-PET) in a patient with pulmonary sarcoidosis prior to and during treatment with inhaled corticosteroids followed by systemic corticosteroids. The patient was a 41-year-old man presenting with stage I pulmonary sarc...
PET Scans With 18F-Fluorodeoxyglucose to Diagnose Adrenal Tumors To the Editor In the JAMA Clinical Challenge of a patient with a large adrenal tumor, we question the need for a positron emission tomography (PET)/computed tomography (CT) scan using F-fluorodeoxyglucose (F-FDG) in establishing th...
Increasing age at diagnosis of chronic uveitis (p=0.01), presence of posterior synechiae (p=0.01) and positive chest HRCT (p=0.01) were factors associated with probability to have a PET scan with signs for sarcoidosisConclusion increasing age at the diagnosis of uveitis, presence of posterior ...
The parameter settings were as follows: matrix size, 144 × 144; slice thickness, 5 mm; field of view, 576 mm; and emission scan time, 1.5 min for each bed position. PET/CT image segmentation and feature extraction LIFEX software tools were used for volume of interest (VOI) ...
Interpretation & conclusions: 18F-FDG PET/CT has a good sensitivity and NPV for detecting BMI in HL and aggressive lymphoma. The low specificity and PPV improved if marrow uptake pattern on interim or end-of-treatment 18F-FDG PET/CT scan was analyzed. In patients with HL who are staged ...
FDG PET-CT scan performed 3 months after SBRT for non-small cell lung cancer (NSCLC) had a sensitivity of 50% (95% CI, 0.26-0.75), a specificity of 94% (95% CI, 0.89-1.0), a positive predictive value of 67% (95% CI, 0.4-0.93), and a negative predictive value of 89% (95%...
Assessing the usefulness of 18F- fluorodeoxyglucose PET-CT scan after stereotactic body radiotherapy for early-stage non-small cell lung cancer. Chest. 2014;146:406-411.Pastis NJ, Greer TJ, Tanner NT, Wahlquist AE, Gordon LL, Sharma... NJPJ A,TJG A,NTT A,... - 《Chest the Journal of...
Methods Patient selection The Mayo Clinic Medical Records Linkage system was queried to identify all patients seen in the Department of Neurology between January 1, 2005, and September 30, 2008, who had a clinical diagnosis of progressive aphasia or AOS and had an FDG-PET scan. To capture pati...
The use of fluorodeoxyglucose positron emission to-mography(FDG PET) scan technology in the manage-ment of head and neck cancers continues to increase. We discuss the biology of FDG uptake in malignant lesions and also discuss the physics of PET imaging. The various parameters described to quanti...